Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity-Reference-Cited by-同舟云学术

Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity

Published:2013-08-08 Issue:6 Volume:122 Page:1088-1089
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Flanders Aaron¹,Stetler-Stevenson Maryalice²,Landgren Ola¹

Affiliation:

1. Multiple Myeloma Section, National Cancer Institute, Bethesda, MD

2. Flow Cytometry Section, National Cancer Institute, Bethesda, MD

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/6/1088/1374969/1088.pdf

Reference5 articles.

1. Treating myeloma: the future is already here!;Landgren;Blood,2012

2. Comparison of immunofixation, serum free light chain, and immunophenotyping for response evaluation and prognostication in multiple myeloma.;Paiva;J Clin Oncol,2011

3. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.;Rawstron;Haematologica,2008

4. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.;Liu;J Clin Pathol,2012

5. Multiparameter immunophenotyping by flow cytometry in multiple myeloma: the diagnostic utility of defining ranges of normal antigenic expression in comparison to histology.;Cannizzo;Cytometry B Clin Cytom,2010

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases;Medicine of Extreme Situations;2023-12

2. Voyage of Measurable Residual Disease Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry;Indian Journal of Medical and Paediatric Oncology;2023-04-24

3. Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies;Cancers;2022-06-21

4. Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis;Cytometry Part B: Clinical Cytometry;2022-01-10

5. Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients;The Journal of Molecular Diagnostics;2022-01